Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: A Workshop on Lessons Learned

The National Academies of Sciences, Engineering, and Medicine

Past Event


This event has passed.

Have a look at more upcoming events like this

Registration Required


The National Academies of Sciences, Engineering, and Medicine





Data & Technology


On July 26 and 27, 2021, the National Cancer Policy Forum will convene a virtual workshop to examine changes in cancer research and care that occurred in response to the COVID-19 pandemic, and consider lessons learned from that experience in order to improve the conduct of cancer clinical trials and the delivery of high-quality cancer care in the post-pandemic era, with an emphasis on health equity. The workshop will feature invited presentations and panel discussions on topics that may include:

  • A review of clinical practice changes, such as increased use of telehealth, and their impact on cancer research and care.
  • Opportunities and strategies to retain and build on beneficial changes that advance the delivery of high-quality cancer care (e.g., by improving patient-centeredness, accessibility, equity, and affordability), and improve the conduct of cancer clinical trials (e.g., by facilitating inclusive, community-based clinical trials, leveraging digital tools and technologies).
  • Policy and regulatory modifications that may be needed to continue beneficial changes in cancer care and clinical trials.

Confirmed Speakers:

Kald Abdallah, Bristol Myers Squibb
Sundeep Agrawal, Food and Drug Administration
Derek Angus, University of Pittsburgh Medical Center
Dietmar P. Berger, Sanofi (representing TransCelerate)
Shonta Chambers, Patient Advocate Foundation
Loretta Christensen, Indian Health Service
William Dahut, National Cancer Institute
James H. Doroshow, National Cancer Institute
Lee Fleisher, Centers for Medicare & Medicaid Services
Shelley Fuld Nasso, National Coalition for Cancer Survivorship
Elizabeth Garrett-Mayer, American Society of Clinical Oncology
Randall N. Hyer, Moderna, Inc.
Paul Jacobsen, National Cancer Institute
Michael J. Kelley, Duke University Medical Center/Durham VA Medical Center
Paul Kluetz, Food and Drug Administration
Karen E. Knudsen, American Cancer Society
Christopher Lathan, Dana-Farber Cancer Institute/Harvard Medical School
Inga T. Lennes, Massachusetts General Hospital
Douglas Lowy, National Cancer Institute
Michael McNeely, Health Resources and Services Administration
Fareed Melhem, Medidata Solutions
Marcella Nunez-Smith, Presidential COVID-19 Health Equity Task Force/Yale School of Medicine
Randall A. Oyer, Association of American Cancer Centers/Penn Medicine Lancaster General
Steven Pergam, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Jane Perlmutter, Patient Advocate
Lori Pierce, American Society of Clinical Oncology
Leonard Sacks, Food and Drug Administration
Bhuvana Sagar, Cigna Health Care
Lawrence Shulman, University of Pennsylvania Abramson Cancer Center
David Spigel, Sarah Cannon Research Institute
Lara Strawbridge, Center for Medicare & Medicaid Innovation
Karen M. Winkfield, Meharry-Vanderbilt Alliance
Robert A. Winn, VCU Massey Cancer Center
Robin Zon, Michiana Hematology Oncology



The National Academies of Sciences, Engineering, and Medicine